In the article entitled, “Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions” (Volume 190, pages 2000–2012 of the October 2020 issue of The American Journal of Pathology; DOI: https://doi.org/10.1016/j.ajpath.2020.07.012, the authors have noted some errors in the funding and disclosure statements as published. Corrected funding and disclosure statements are below:
Supported by Sylvester Comprehensive Cancer Center grant PG005185 (S.N.C., R.B.L.); NIH grants R01AI148675 (T.R.M.), R01AI131648 (T.R.M.), R01 EY024484 (R.B.L.), R01 EY030283 (R.B.L.), and R41 AI149916 (R.B.L.); and Heat Biologics/Pelican Therapeutics SRA GR010438 (R.B.L.).
Disclosures: R.B.L. is a compensated consultant/advisory board member and equity holder in Heat Biologics.